High-volume cancer centers utilizing neoadjuvant chemotherapy (NACT) significantly reduce surgical mortality and enhance survival rates in patients with advanced ovarian cancer.

Ambulatory cardiac monitors’ clinical and economic outcomes vary; one long-term continuous monitor brand showed greater arrhythmia diagnosis, fewer retests and cardiovascular events, and lower health ...

The cause of dilated cardiomyopathy (DCM) can be associated with the presence of the TTN gene combined with preexisting comorbidities like atrial fibrillation, which increase the odds of developing ...

Continuing his interview about these results, CEPHEUS lead investigator Saad Z. Usmani, MD, MBA, FACP, FASCO, highlights the minimal residual disease negativity findings.

The inverse variance-weighted analysis suggested that large artery atherosclerosis stroke had a negative impact on IPF risk, ...

Investigators say they have created a set of models that can use common electronic health record (EHR) data to predict a ...

A multicenter study finds no difference in outcomes between frail and nonfrail elderly patients treated with tildrakizumab ...

Patient satisfaction was higher amongst patients who underwent a chest wall perforator flap reconstruction surgery as part of ...

Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation ...

Brensocatib (Brinsupri; Insmed) gains FDA approval as the first treatment for bronchiectasis, offering hope to patients with ...

There is a need to consolidate various long COVID definitions to establish a standardized definition that ensures consistent recognition, documentation, diagnosis, and treatment, according to new ...

Jason Bergsbaken, PharmD, MBA, BCOP, highlights the growing role of real-world data in validating or de-implementing therapies, the need for vigilant postapproval outcomes monitoring, and the value of ...